Canine Diabetes Mellitus

Jul 18, 2016 by in PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS Comments Off on Canine Diabetes Mellitus

Chapter 44 Canine Diabetes Mellitus William E. Monroe,     Blacksburg, Virginia Definition, Epidemiology, and Pathophysiology Diabetes mellitus in dogs is a persistent defect of carbohydrate metabolism associated with an absolute deficiency of…

read more

Diabetic Monitoring

Jul 18, 2016 by in PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS Comments Off on Diabetic Monitoring

Chapter 45 Diabetic Monitoring Claudia E. Reusch,     Zurich, Switzerland The aim of therapy in diabetic pets is to eliminate the clinical signs of diabetes mellitus, prevent short-term complications (e.g., hypoglycemia, ketoacidosis),…

read more

Thromboelastography

Jul 18, 2016 by in PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS Comments Off on Thromboelastography

Chapter 15 Thromboelastography Karl E. Jandrey,     Davis, California Benjamin M. Brainard,     Athens, Georgia Viscoelastic point-of-care coagulation instruments have become more popular owing to their unique ability to detect both hypocoagulability and hypercoagulability…

read more

Aflatoxicosis in Dogs

Jul 18, 2016 by in PHARMACOLOGY, TOXICOLOGY & THERAPEUTICS Comments Off on Aflatoxicosis in Dogs

Chapter 38 Aflatoxicosis in Dogs Karyn Bischoff,     Ithaca, New York Tam Garland,     College Station, Texas Aflatoxicosis in dogs was first described as hepatitis X in 1952. The disease was experimentally reproduced in…

read more
Get Clinical Tree app for offline access